Cathay Biotech Inc. Stock Analysis 688065.SS

Cathay Biotech Inc. engages in the research and development, production and sales of new bio-based materials. The company is headquartered in Shanghai, Shanghai and currently employs 1,761 full-time employees. The company went IPO on 2020-08-12. The Company’s main products include a series of biological long-chain dibasic acids (DC10-DC18), bio-based pentamethylenediamine, and a series of bio-based polyamides. The firm's products are mainly used in textiles, engineering materials, transportation logistics, building materials, new energy, medicine, electronic appliances, daily consumer goods and other fields. The firm's brands include TERRYL, a bio-based polyamide fiber brand for the textile sector, and ECOPENT, a brand for engineering materials. The firm mainly operates its businesses in the domestic and overseas markets.